These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10713012

  • 1. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.
    van Heerden PV, Barden A, Michalopoulos N, Bulsara MK, Roberts BL.
    Chest; 2000 Mar; 117(3):819-27. PubMed ID: 10713012
    [Abstract] [Full Text] [Related]

  • 2. Systemic levels of 6-keto-prostaglandin F1 alpha following administration of inhaled aerosolized prostacyclin.
    van Heerden PV.
    Anaesth Intensive Care; 1997 Dec; 25(6):701-3. PubMed ID: 9452859
    [Abstract] [Full Text] [Related]

  • 3. Description and evaluation of a delivery system for aerosolized prostacyclin.
    Siobal MS, Kallet RH, Pittet JF, Warnecke EL, Kraemer RW, Venkayya RV, Tang JF.
    Respir Care; 2003 Aug; 48(8):742-53. PubMed ID: 12890294
    [Abstract] [Full Text] [Related]

  • 4. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia.
    Van Heerden PV, Webb SA, Hee G, Corkeron M, Thompson WR.
    Anaesth Intensive Care; 1996 Feb; 24(1):87-90. PubMed ID: 8669661
    [Abstract] [Full Text] [Related]

  • 5. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
    Searcy RJ, Morales JR, Ferreira JA, Johnson DW.
    Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
    [Abstract] [Full Text] [Related]

  • 6. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
    Van Heerden PV, Blythe D, Webb SA.
    Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
    [Abstract] [Full Text] [Related]

  • 7. Severity of Hypoxemia and Other Factors That Influence the Response to Aerosolized Prostacyclin in ARDS.
    Kallet RH, Burns G, Zhuo H, Ho K, Phillips JS, Pangilinan LP, Yip V, Gomez A, Lipnick MS.
    Respir Care; 2017 Aug; 62(8):1014-1022. PubMed ID: 28559468
    [Abstract] [Full Text] [Related]

  • 8. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
    Meyer J, Theilmeier G, Van Aken H, Bone HG, Busse H, Waurick R, Hinder F, Booke M.
    Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin.
    Rocca GD, Coccia C, Pompei L, Ruberto F, Venuta F, De Giacomo T, Pietropaoli P.
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):224-7. PubMed ID: 11312484
    [Abstract] [Full Text] [Related]

  • 11. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury.
    Dahlem P, van Aalderen WM, de Neef M, Dijkgraaf MG, Bos AP.
    Crit Care Med; 2004 Apr; 32(4):1055-60. PubMed ID: 15071401
    [Abstract] [Full Text] [Related]

  • 12. Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response.
    Domenighetti G, Stricker H, Waldispuehl B.
    Crit Care Med; 2001 Jan; 29(1):57-62. PubMed ID: 11176161
    [Abstract] [Full Text] [Related]

  • 13. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.
    Zwissler B, Kemming G, Habler O, Kleen M, Merkel M, Haller M, Briegel J, Welte M, Peter K.
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1671-7. PubMed ID: 8970353
    [Abstract] [Full Text] [Related]

  • 14. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.
    Walmrath D, Schneider T, Schermuly R, Olschewski H, Grimminger F, Seeger W.
    Am J Respir Crit Care Med; 1996 Mar; 153(3):991-6. PubMed ID: 8630585
    [Abstract] [Full Text] [Related]

  • 15. Inhaled aerosolized prostaglandin E1, pulmonary hemodynamics, and oxygenation during lung transplantation.
    Della Rocca G, Coccia C, Pompei L, Costa MG, Di Marco P, Pietropaoli P.
    Minerva Anestesiol; 2008 Nov; 74(11):627-33. PubMed ID: 18971891
    [Abstract] [Full Text] [Related]

  • 16. Re: Delivery of inhaled aerosolized prostacyclin (IAP).
    van Heerden PV, Power BM, Leonard RC.
    Anaesth Intensive Care; 1996 Oct; 24(5):624-5. PubMed ID: 8909691
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?
    Eichelbrönner O, Reinelt H, Wiedeck H, Mezödy M, Rossaint R, Georgieff M, Radermacher P.
    Intensive Care Med; 1996 Sep; 22(9):880-7. PubMed ID: 8905421
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome.
    Camamo JM, McCoy RH, Erstad BL.
    Pharmacotherapy; 2005 Feb; 25(2):184-90. PubMed ID: 15767234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.